Status:
COMPLETED
NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden
Lead Sponsor:
Ferring Pharmaceuticals
Conditions:
Adverse Drug Event
Eligibility:
All Genders
18+ years
Brief Summary
A study using medical records to evaluate safety issues for the NOCDURNA drug using national register data from Denmark and Sweden, and a health care register covering parts of Germany.
Eligibility Criteria
Inclusion
- Usage of NOCDURNA recorded as dispensations in adults or usage of drugs for LUTS.
Exclusion
- Multiple dispensations of NOCDURNA on the same day or treatment with vasopressin 6 months before study start.
Key Trial Info
Start Date :
July 13 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2023
Estimated Enrollment :
1099551 Patients enrolled
Trial Details
Trial ID
NCT04740645
Start Date
July 13 2021
End Date
November 1 2023
Last Update
December 3 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Danish Health Care Registry
Copenhagen, Denmark
2
German Health Care Register
Bremen, Germany
3
Socialstryrelsen
Stockholm, Sweden